Menu SECTIONS
  • News
  • Features
  • CME
  • Conferences
  • Clinical Tools
  • Special Collections
  • Multimedia
  • Topics
    • Allergies
    • Critical Care Medicine
    • Disorders of Sleep and Breathing
    • Disorders of the Pulmonary Circulation
    • General Medicine
    • General Pulmonology
    • Lung Cancer
    • Obstructive Lung Diseases
    • Pleural and Mediastinal Disorders
    • Practice Management
    • Respiratory Infectious Disease
    • Restrictive Lung Diseases
  • Haymarket Medical Network
    • Cancer Therapy Advisor
    • Clinical Advisor
    • Clinical Pain Advisor
    • Dermatology Advisor
    • Endocrinology Advisor
    • Gastroenterology Advisor
    • Hematology Advisor
    • Infectious Disease Advisor
    • MPR
    • Medical Bag
    • Neurology Advisor
    • Oncology Nurse Advisor
    • Ophthalmology Advisor
    • Optometry Advisor
    • Psychiatry Advisor
    • Pulmonology Advisor
    • Rare Disease Advisor
    • Renal and Urology News
    • Rheumatology Advisor
    • The Cardiology Advisor
  • News
  • Calculators
  • Charts
  • CME
  • Drugs
  • Resources
  • Meetings
  • Multimedia
Part of the
  • News and Features
  • CME
  • Conferences
  • Clinical Tools
  • Special Collections
  • Multimedia

news
Childhood Exposure to Violence, Abuse Increases Risk for Asthma in Youth, Adults

Researchers explored the link between exposure to violence or abuse during childhood and youth/adult asthma in those with high Th2 immunity.

Publish Date May 24, 2023
news
Supervised PH Exercise Training Significantly Improves Exercise Capacity, QoL

An updated Cochrane Review re-examined outcomes of exercise-based rehabilitation in individuals with pulmonary hypertension.

Publish Date May 24, 2023
news
Mandibular Device as First-Line OSA Therapy Shows High Adherence, Effectiveness

A clinical trial is assessing the effectiveness of a mandibular advancement device (MAD) as first-line therapy for patients with moderate to severe OSA.

Publish Date May 24, 2023
news
Home Oscillometry for COPD Allows Early Detection, Prevention of Exacerbations

Researchers assessed whether home oscillometry could identify early symptoms of AECOPD, thus preventing acute exacerbations.

Publish Date May 24, 2023
news
Inpatients With Sarcoidosis on Medicaid and Medicare Have Worse Outcomes

How does having Medicare or Medicaid vs private insurance affect the outcomes of patients hospitalized for sarcoidosis?

Publish Date May 24, 2023
news
Many Black, Latinx Adults Prefer Telehealth Visits for Asthma-Related Care

Researchers surveyed Black and Latinx adults with moderate to severe asthma to determine their preferences with respect to telehealth visits vs in-person asthma care.

Publish Date May 24, 2023
news
Patients With Asthma, Obesity Have Increased Risk for Near-Fatal Asthma Events

Research presented at the AAAAI annual meeting explored whether obesity is a risk factor for fatal or near-fatal events in those experiencing asthma exacerbations.

Publish Date February 27, 2023
news
Adults With Asthma More Likely to Have Psychological Distress and Depression

Investigators characterized the mental health burden experienced by adults with asthma, along with assessing their level of patient satisfaction.

Publish Date February 27, 2023
news
Race/Ethnicity and Insurance Biases Limit Asthma Biologic Prescription, Use

Investigators sought to determine biologic prescription and adherence rates among adults receiving outpatient care for asthma.

Publish Date February 27, 2023
news
Clinicians Unaware of Some NIH/NHLBI 2020 Focused Updates of Asthma Guidelines

A survey presented at AAAAI 2023 assessed clinicians’ awareness and understanding of the NIH/National Heart, Lung, and Blood Institute 2020 updated asthma guidelines.

Publish Date February 27, 2023
news
Survey Tool Predicts Risk for Exacerbations in Very Poorly Controlled Asthma

Researchers assessed the value of the Asthma Impairment and Risk Questionnaire for predicting risk for multiple exacerbations in those with very poorly controlled asthma.

Publish Date February 27, 2023
news
Parasitic Infection Common Cause of Persistent Eosinophilia in Inner-City Patients

The underlying causes of persistent, unexplained eosinophilia were explored among patients of an inner-city allergy clinic.

Publish Date November 21, 2022
news
Risk of Ischemic Heart Disease Increased in Patients With Asthma

Building on research showing greater risk for IHD among women with adult-onset asthma, researchers examined the link between IHD and asthma severity.

Publish Date November 21, 2022
news
COVID-19 Vaccine Allergy Program Helps to Overcome Vaccine Hesitancy

A study tested the effects of a COVID-19 Vaccine Allergy Program using skin prick testing and shared decision-making on vaccine-hesitant health care workers.

Publish Date November 21, 2022
news
Berotralstat Reduces Real-World Attack Rates in Hereditary Angioedema

How well does berotralstat control hereditary angioedema in a real-world population over the course of a year?

Publish Date November 21, 2022
news
Single-Day Oral Desensitization for Aspirin-Exacerbated Respiratory Disease

Researchers analyzed patients with aspirin-exacerbated respiratory disease to determine the safety and efficacy of a one-day oral aspirin desensitization protocol.

Publish Date November 21, 2022
news
Albuterol/Budesonide Associated With Fewer Asthma Exacerbations

Study authors explored the effect of albuterol/budesonide fixed combination therapy on asthma deterioration and severe asthma exacerbations compared with albuterol, budesonide, or placebo.

Publish Date November 21, 2022
news
COVID-19 Vaccine Split-Dosing Proves Safe, Noninferior to Conventional Dosing

How does split dosing of COVID-19 vaccines compare with conventional dosing with respect to antibody responsiveness and safety?

Publish Date November 17, 2022
news
Exacerbation Risk Exists for Patients With All Levels of Asthma Control/Severity

In patients using as-needed short-acting beta2-agonists, how are exacerbations associated with asthma control, maintenance adherence, and disease severity?

Publish Date November 17, 2022
news
Use of Biologics Reduces Exacerbations, Emergency Visits in Pediatric Asthma

A real-world study assessed how pediatric patients with moderate to severe asthma responded to the use dupilumab, mepolizumab, and omalizumab.

Publish Date November 17, 2022
news
Azelastine HCl 0.15% Nasal Spray Rapidly Relieves Seasonal Allergy Symptoms

How rapid is the onset of effective action when using azelastine HCl 0.15% to relieve nasal symptoms of seasonal allergic rhinitis?

Publish Date November 17, 2022
news
Mepolizumab Shows Real-World Efficacy in Allergic and Non-Allergic Asthma

While mepolizumab has proven safe and effective for severe asthma, how has it performed in treating those with allergic vs non-allergic asthma?

Publish Date November 17, 2022
news
Researchers Link Smell Loss, Disease Burden, and Dupilumab Efficacy in CRSwNP

Researchers assessed the link between smell loss in CRSwNP and other disease attributes, as well as the effect of dupilumab according to smell loss severity.

Publish Date November 17, 2022
news
Allergen Exposure, Other Factors Predict Limited Airflow in Pediatric Asthma

What are the most significant predictors of airflow limitation in children 5 to 18 years of age with severe asthma?

Publish Date November 16, 2022
news
Certain Clinical Markers May Predict AERD in Patients With CRSwNP

Which clinical screening markers predict aspirin-exacerbated respiratory disease in patients with chronic rhinosinusitis with nasal polyps?

Publish Date November 16, 2022
news
Early Atopic Dermatitis Modifies the Risk for Allergic Respiratory Disease

How does having atopic dermatitis at 2 years of age affect the risk of developing allergic respiratory disease by 10 years of age?

Publish Date November 16, 2022
news
Epicutaneous Immunotherapy Safe, Effective in Toddlers With Peanut Allergy

The phase 3 EPITOPE trial assessed the safety and efficacy of epicutaneous immunotherapy for peanut allergy in children under 4 years old.

Publish Date November 16, 2022
news
Safety of Lebrikizumab Similar to Placebo in Patients With Uncontrolled Asthma

Researchers analyzed pooled safety data from 3 clinical trials of lebrikizumab for uncontrolled asthma to determine the drug’s safety profile.

Publish Date November 16, 2022
news
Uncontrolled Asthma in Hispanic/Latino Patients Improved With Tezepelumab

A post hoc analysis of the PATHWAY and NAVIGATOR trials assessed efficacy of tezepelumab in Hispanic/Latino patients with severe, uncontrolled asthma.

Publish Date November 16, 2022
news
Maintenance and Reliever Digital System vs Standard Care Improves Asthma Control

Researchers evaluated asthma control in participants receiving maintenance and reliever digital system vs standard maintenance and reliever inhalers.

Publish Date November 15, 2022
Page 1 of 2
Page 1 Page 2 Next page Last page
  • Latest News Your top articles for Friday

    For More Personalized News
  • Haymarket Medical NetworkTop Picks

  • Loading...

    Continuing Medical Education (CME/CE) Courses

    Show More

    • ABOUT
    • ADVERTISE
    • CONNECT
    Remarkable healthcare content
    Cancer Therapy Advisor
    Clinical Advisor
    Clinical Pain Advisor
    Dermatology Advisor
    Endocrinology Advisor
    Gastroenterology Advisor
    Hematology Advisor
    Infectious Disease Advisor
    MPR
    McKnight’s Home Care
    McKnight’s Long-term Care
    McKnight’s Senior Living
    Medical Bag
    Neurology Advisor
    Oncology Nurse Advisor
    Ophthalmology Advisor
    Optometry Advisor
    Psychiatry Advisor
    Pulmonology Advisor
    Rare Disease Advisor
    Renal and Urology News
    Rheumatology Advisor
    The Cardiology Advisor
    myCME

    Copyright © 2023 Haymarket Media, Inc. All Rights Reserved. This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media’s Privacy Policy and Terms & Conditions.

    Loading...
    Loading...